Skip to main content

Wettig Thane's Form 4/A amendment

Amended

Kyntra Bio, Inc.KYNB · filed Jun 22, 2023

Accession no.
0001209191-23-039157
Filed
Jun 22, 2023
Trade date
Jun 7, 2023
Filing delay
15 days
Rule 10b5-1 plan
Not checked
Original filed
Jun 9, 2023

This filing lists 2 non-derivative transactions. Open-market sales total $30.0K. It was filed 15 days after the trade.

This amendment replaces 0001209191-23-036066 (filed Jun 9, 2023).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wettig ThaneCIK 0001815638Officer (Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 7, 2023Common StockSSaleDisposed−472$17.04−$8,042.88110,338Direct
Jun 7, 2023Common StockSSaleDisposed−1,286$17.04−$21,913.44109,052Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.

F2

Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan.

Remarks

This amendment to Form 4 is being filed solely to correct an inadvertent math error contained in the end of period holdings in Box 5 of the Form 4 filed on June 9, 2023.

Read the full filing on SEC EDGAR (opens in a new tab)